Rate and adequacy of cholesterol screening in patients admitted to a large rehabilitation unit after stroke

Archives of Physical Medicine and Rehabilitation

Volumn 86, Issue 1, 2005, Pages 69-72

  Bogar, Mark D ^a   Basford, Jeffrey R ^b,c   Thomas, Randal J ^b  

^a Phys Med and Rehab Associates   (United States)

^b MAYO CLINIC   (United States)

^c Mayo Clinic ^*  (United States)

Author keywords

Cerebrovascular disorders; Heart disease; Hyperlipidemia; Rehabilitation; Stroke

Indexed keywords

ATORVASTATIN; CHOLESTEROL; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; SIMVASTATIN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; RETROSPECTIVE STUDY; SCREENING;

ADULT; AGED; AGED, 80 AND OVER; CEREBROVASCULAR ACCIDENT; CHOLESTEROL; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MIDWESTERN UNITED STATES; PATIENT ADMISSION; REHABILITATION CENTERS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 11444268403     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apmr.2003.12.034     Document Type: Article

References (20)

1. Matsumoto N., Whisnant J.P., Kurland L.T., Okazaki H. Natural history of stroke in Rochester, Minnesota, 1955 through 1969 an extension of a previous study, 1945 through 1954. Stroke. 4:1973;20-29
2. von Arbin M., Britton M., de Faire U., Helmers C., Miah K., Murray V. Acute myocardial infarction in acute stroke. Eur Heart J. 3:1982;136-141
3. Rokey R., Rolak L.A., Harati Y., Kutka N., Verani M.S. Coronary artery disease in patients with cerebrovascular disease a prospective study. Arch Neurol. 16:1984;50-53
4. Young J.R., Hertzer N.R., Beven E.G., et al. Coronary artery disease in patients with aortic aneurysm a classification of 302 coronary angiograms and results of surgical management. Ann Vasc Surg. 1:1986;36-42
5. DiPasquale G., Andreoli A., Carini G. Use of dipyridamole-thallium myocardial imaging. Cerebrovasc Dis. 1:1991;31-37
6. Roth E.J. Heart disease in patients with stroke: incidence, impact, and implications for rehabilitation. Part 1: Classification and prevalence. Arch Phys Med Rehabil. 74:1993;752-760
7. Kernan W.N., Inzucchi S.E., Viscoli C.M., Brass L.M., Bravata D.M., Horwitz R.I. Insulin resistance and risk for stroke. Neurol. 59:2002;809-815
8. Droste D.W., Ritter M.A., Dittrich R., et al. Arterial hypertension and ischaemic stroke. Acta Neurol Scand. 107:2003;241-251
9. Ridker P.M., Genest J., Libby P. Risk factors for atherosclerotic disease. Braunwald E., Zipes D.P., Libby P. Heart disease a textbook of cardiovascular medicine. 6th ed:2001;1010-1039 WB Saunders, Philadelphia
10. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S). Lancet. 344:(8934):1994;1383-1389
11. Pfeffer M.A., Sacks F.M., Moye L.A., et al. CARE Investigators. Cholesterol and Recurrent Events a secondary prevention trial for normolipidemic patients. Am J Cardiol. 76:1995;98C-106C
12. Summary of the second report of the National Cholesterol Education Program (NCEP). Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 269:1993;3015-3023
13. Luepker R.V. Current status of cholesterol treatment in the community the Minnesota Heart Survey. Am J Med. 102:1997;37-42
14. Pearson T.A., Laurora I., Chu H., Kafonek S. The Lipid Treatment Assessment Project (L-TAP) a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med. 160:2000;459-467
15. Lalouschek W., Lang W., Greisenegger S., Müllner M. Determinations of lipid profiles and use of statins in patients with ischemic stroke or transient ischemic attack. Stroke. 34:2003;105-110
16. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502
17. Myers G.L., Cooper G.R., Winn C.L., Smith S.J. The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements. Clin Lab Med. 9:1989;105-135
18. Butterworth R.J., Marshall W.J., Bath P.M. Changes in serum lipid measurements following acute ischaemic stroke. Cerebrovasc Dis. 7:1997;10-13
19. Bairey Merz C.N., Felando M.N., Klein J. Cholesterol awareness and treatment in patients with coronary artery disease participating in cardiac rehabilitation. J Cardiopulm Rehabil. 16:1996;117-122
20. Division P. Population estimates program. 2000;US Census Bureau, Washington (DC)